Clinical trial
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
NCT00000433 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00000433 |
|---|---|
| Title | Blocking Tumor Necrosis Factor in Ankylosing Spondylitis |
| Official title | Anti-Tumor Necrosis Factor (TNFR:Fc) in Ankylosing Spondylitis |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Spondylitis, Ankylosing |
| Intervention type | Drug |
| Interventions | Anti-Tumor Necrosis Factor |
| Enrollment | 42 |
| Start date | Oct 1, 1999 |
| Completion | Mar 1, 2002 |
| First posted | Jan 19, 2000 |
| Last update posted | Jan 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: